Review
Version 2
Preserved in Portico This version is not peer-reviewed
Influenza Virus Infection, Interferon Response, Viral Counter-Response, and Apoptosis
Version 1
: Received: 30 May 2017 / Approved: 30 May 2017 / Online: 30 May 2017 (07:13:09 CEST)
Version 2 : Received: 12 August 2017 / Approved: 14 August 2017 / Online: 14 August 2017 (04:41:22 CEST)
Version 2 : Received: 12 August 2017 / Approved: 14 August 2017 / Online: 14 August 2017 (04:41:22 CEST)
A peer-reviewed article of this Preprint also exists.
Abstract
Human influenza A viruses (IAVs) cause global pandemics and epidemics, which remain serious threats to public health because of the shortage of effective means of control. To combat the surge of viral outbreaks, new treatments are urgently needed. Developing new virus control modalities requires better understanding of virus-host interactions. Here we describe how IAV infection triggers cellular apoptosis, and how this process can be exploited towards development of new therapeutics, which might be more effective than the currently available anti-influenza drugs.
Keywords
influenza virus; apoptosis; antiviral agent; innate immunity; host response
Subject
Biology and Life Sciences, Immunology and Microbiology
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment